AMERIPRISE FINANCIAL INC
Position in REGN — Regeneron Pharmaceuticals, Inc.
CIK 820027
MINNEAPOLIS, MN
Position in REGN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$246,995,233
+$21,671,717 QoQ
Shares Held
319,677
+9.5% QoQ
Ownership
0.305%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 65.37942986201696.ToString("F0")%
None 34.62057013798302.ToString("F0")%
Common Shares in REGN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026AMERIPRISE FINANCIAL INC holds $4,230,069,783 across 189 Biotechnology names. REGN ranks #4 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
2,633,481 | $1,175,954,602 | |
| 2 | INSM |
INSMED Inc
|
3,057,718 | $499,998,043 | |
| 3 | JAZZ |
Jazz Pharmaceuticals plc
|
1,608,476 | $304,082,386 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
319,677 | $246,995,233 | |
| 5 | ARGX |
Argenx SE
|
215,910 | $157,668,275 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,579,793 | $153,634,868 | |
| 7 | ASND |
Ascendis Pharma A/S
|
476,466 | $108,982,067 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,248,521 | $92,715,166 |
All Filings in REGN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $246,995,233 | 319,677 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $225,323,516 | 291,919 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $159,181,445 | 283,105 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $151,041,975 | 287,699 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $215,730,160 | 340,145 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $232,612,071 | 326,551 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $385,551,728 | 366,759 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $394,008,022 | 374,878 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $320,071,235 | 332,545 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $294,974,571 | 335,851 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $300,935,073 | 365,674 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $270,550,427 | 376,528 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $294,115,130 | 357,948 | Shares | Defined | 2023-05-22 | |
| 2022-12-31 | $241,961,769 | 335,364 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $203,561,082 | 295,500 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $182,325,769 | 308,436 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $278,551,544 | 398,831 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $257,026,111 | 406,996 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $230,373,262 | 380,669 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $229,725,824 | 411,297 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $134,639,555 | 284,566 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $131,812,695 | 272,842 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $154,838,505 | 276,606 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $169,880,387 | 272,397 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $141,160,729 | 289,092 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||